Andrew Peaple (@andypeaps.bsky.social)

Still, patented drugs sourced from abroad or made by U.S.-Chinese joint ventures tend to be more effective, says Yanzhong Huang at CFR “You have this mutual dependence,” he says. “Each side is discouraged from making pharmaceuticals and medical devices a target for the trade war.”

loading . . .

The Trade War’s Pharma Carve-Out - The Wire China This week, Noah Berman looks at the medicines and other pharmaceutical products moving between the U.S. and China. https://buff.ly/Es2cxWL